Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Adv Funct Mater. 2020 Sep 9;30(49):2005531. doi: 10.1002/adfm.202005531

Figure 7.

Figure 7.

a, b) Relative miR-26a expression in rBMSCs mediated by Lipo2000-, PEI-, PGEA-, and HA-SS-PGEA-containing NPs, relative to the internal reference U6. c) VEGF expression in rBMSCs mediated by HA-SS-PGEA/miR-NC and HA-SS-PGEA/miR-26a at the N/P ratio of 20 after transfection for 2, 3, 4, and 5 days. d) Relative mRNA expression of GSK-3β in rBMSCs mediated by HA-SS-PGEA/miR-NC and HA-SS-PGEA/miR-26a at the N/P ratio of 20 after transfection for 2, 3, 4, and 5 days. The internal reference is GAPDH. e, f) Relative mRNA expressions of Runx2, Alp, OCN, and BSP in rBMSCs mediated by HA-SS-PGEA/miR-NC and HA-SS-PGEA/miR-26a at the N/P ratio of 20 after 7 d and 21 d of culture in osteo-differentiation medium (*p < 0.05; n = 3 per group). The internal reference is GAPDH.